Allergic conjunctivitis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
 
(5 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}} {{AE}} {{Sujaya}}
{{CMG}} {{AE}} {{Sujaya}}
==Overview==
==Overview==
[[Allergic]] [[conjunctivitis]] is usually a non-progressive [[condition]] with a favorable [[prognosis]], and rare but serious [[complications]]. Most [[symptoms]] are self-limiting, while in some subtypes, a temporal association can be found with the age group and specific [[triggers]].
[[Complications]] include [[infections]], [[scarring]] and can also damage the [[cornea]] and [[eyelids]].
Long-term [[prognosis]] is influenced by the recurrence of the attacks and [[side-effects]] of [[treatment]].
==Natural History==
==Natural History==
===Simple [[allergic]] [[conjunctivitis]]===
===Simple [[allergic]] [[conjunctivitis]]===
Line 8: Line 12:
===[[Vernal]] [[Keratoconjunctivitis]]===
===[[Vernal]] [[Keratoconjunctivitis]]===
Complete resolution without the return of [[symptoms]] after adolescence is observed in a majority of patients.
Complete resolution without the return of [[symptoms]] after adolescence is observed in a majority of patients.
===Atopic Keratoconjunctivitis===
===[[Atopic]] [[Keratoconjunctivitis]]===
Uncommon before adolescence and peaks from 30 to 50 years of age. Most cases coexist with [[atopic]] [[dermatitis]].
Uncommon before adolescence and peaks from 30 to 50 years of age. Most cases coexist with [[atopic]] [[dermatitis]].


===Giant Papillary Conjunctivitis===
===Giant [[Papillary]] [[Conjunctivitis]]===
* A temporal relationship with contact lens use may explain the predominance of this variety in teens and young adults.
* A temporal relationship with contact lens use may explain the predominance of this variety in teens and young adults.
* It manifests usually after one to two years of wearing soft contact lenses but varies widely with other ocular foreign bodies<ref name="pmid29846426">{{cite journal| author=Sen E, Celik S, Inanc M, Elgin U, Ozyurt B, Yılmazbas P| title=Seasonal distribution of ocular conditions treated at the emergency room: a 1-year prospective study. | journal=Arq Bras Oftalmol | year= 2018 | volume= 81 | issue= 2 | pages= 116-119 | pmid=29846426 | doi=10.5935/0004-2749.20180026 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29846426  }} </ref>.
* It manifests usually after one to two years of wearing soft contact lenses but varies widely with other ocular foreign bodies<ref name="pmid29846426">{{cite journal| author=Sen E, Celik S, Inanc M, Elgin U, Ozyurt B, Yılmazbas P| title=Seasonal distribution of ocular conditions treated at the emergency room: a 1-year prospective study. | journal=Arq Bras Oftalmol | year= 2018 | volume= 81 | issue= 2 | pages= 116-119 | pmid=29846426 | doi=10.5935/0004-2749.20180026 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29846426  }} </ref>.
==Complications==
==Complications==
In most cases, [[allergic]] [[conjunctivitis]] is a [[benign]] condition. [[Complications]] although rare,can be serious and include:
In most cases, [[allergic]] [[conjunctivitis]] is a [[benign]] condition. [[Complications]] although rare,can be serious and include:
Line 19: Line 24:
* Progression to [[infective]] [[conjunctivitis]], leading to serious secondary [[infections]].
* Progression to [[infective]] [[conjunctivitis]], leading to serious secondary [[infections]].
* [[Corneal]] [[opacification]] and [[ulceration]] in [[VKC]] and [[AKC]<ref name="pmid28493631">{{cite journal| author=Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H | display-authors=etal| title=Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. | journal=Allergy | year= 2017 | volume= 72 | issue= 11 | pages= 1597-1631 | pmid=28493631 | doi=10.1111/all.13201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28493631  }} </ref>]  
* [[Corneal]] [[opacification]] and [[ulceration]] in [[VKC]] and [[AKC]<ref name="pmid28493631">{{cite journal| author=Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H | display-authors=etal| title=Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. | journal=Allergy | year= 2017 | volume= 72 | issue= 11 | pages= 1597-1631 | pmid=28493631 | doi=10.1111/all.13201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28493631  }} </ref>]  
* Difficulty in wearing contact lenses due to significant [[lid]] involvement<ref name="pmid28493631">{{cite journal| author=Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H | display-authors=etal| title=Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. | journal=Allergy | year= 2017 | volume= 72 | issue= 11 | pages= 1597-1631 | pmid=28493631 | doi=10.1111/all.13201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28493631  }} </ref>
* Difficulty in wearing contact lenses due to significant [[eyelid]] involvement<ref name="pmid28493631">{{cite journal| author=Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H | display-authors=etal| title=Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. | journal=Allergy | year= 2017 | volume= 72 | issue= 11 | pages= 1597-1631 | pmid=28493631 | doi=10.1111/all.13201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28493631  }} </ref>


==Prognosis==
==Prognosis<ref name="pmid28493631">{{cite journal| author=Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H | display-authors=etal| title=Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. | journal=Allergy | year= 2017 | volume= 72 | issue= 11 | pages= 1597-1631 | pmid=28493631 | doi=10.1111/all.13201 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28493631  }} </ref>==
* PAC and SAC demonstrate favorable long-term outcomes but, significant eye discomfort and poor ocular cosmesis may persist as long-term sequelae in many people.  
* PAC and SAC demonstrate favorable long-term outcomes but, significant eye discomfort and poor ocular cosmesis may persist as long-term sequelae in many people.  
* Recurrences result in [[conjunctivochalasis]], which is a result of ongoing [[limba]] [[conjunctival]] [[chemosis]].
* Recurrences result in [[conjunctivochalasis]], which is a result of ongoing [[limba]] [[conjunctival]] [[chemosis]].

Latest revision as of 18:21, 10 September 2022

Allergic conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Allergic Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Allergic conjunctivitis natural history, complications and prognosis On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Allergic conjunctivitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Allergic conjunctivitis natural history, complications and prognosis

CDC on Allergic conjunctivitis natural history, complications and prognosis

Allergic conjunctivitis natural history, complications and prognosis in the news

Blogs on Allergic conjunctivitis natural history, complications and prognosis

Directions to Hospitals Treating Allergic conjunctivitis

Risk calculators and risk factors for Allergic conjunctivitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

Allergic conjunctivitis is usually a non-progressive condition with a favorable prognosis, and rare but serious complications. Most symptoms are self-limiting, while in some subtypes, a temporal association can be found with the age group and specific triggers. Complications include infections, scarring and can also damage the cornea and eyelids. Long-term prognosis is influenced by the recurrence of the attacks and side-effects of treatment.

Natural History

Simple allergic conjunctivitis

Symptoms are often neglected, and resolve in many patients without medical care.

Vernal Keratoconjunctivitis

Complete resolution without the return of symptoms after adolescence is observed in a majority of patients.

Atopic Keratoconjunctivitis

Uncommon before adolescence and peaks from 30 to 50 years of age. Most cases coexist with atopic dermatitis.

Giant Papillary Conjunctivitis

  • A temporal relationship with contact lens use may explain the predominance of this variety in teens and young adults.
  • It manifests usually after one to two years of wearing soft contact lenses but varies widely with other ocular foreign bodies[1].

Complications

In most cases, allergic conjunctivitis is a benign condition. Complications although rare,can be serious and include:

Prognosis[2]

  • PAC and SAC demonstrate favorable long-term outcomes but, significant eye discomfort and poor ocular cosmesis may persist as long-term sequelae in many people.
  • Recurrences result in conjunctivochalasis, which is a result of ongoing limba conjunctival chemosis.
  • The medications may cause adverse reactions like cataracts.

References

  1. Sen E, Celik S, Inanc M, Elgin U, Ozyurt B, Yılmazbas P (2018). "Seasonal distribution of ocular conditions treated at the emergency room: a 1-year prospective study". Arq Bras Oftalmol. 81 (2): 116–119. doi:10.5935/0004-2749.20180026. PMID 29846426.
  2. 2.0 2.1 2.2 Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H; et al. (2017). "Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis". Allergy. 72 (11): 1597–1631. doi:10.1111/all.13201. PMID 28493631.

Template:WH Template:WS